Venture Valuation conducts an independent valuation of Genedata, a Swiss start-up company in order to help Novartis Venture Fund analyze and structure the next financing round. Venture Valuation, under a tight investment timeframe, has to customize the evaluation process, using both quantitative and qualitative data, to meet the customers needs. The case outlines Genedata’s background, its product portfolio, competitive positioning, and issues that it will need to deal with in the near future. Learning Objective: This case is part of a three case series intended to draw the audience into the issues surrounding the valuation of a startup biotechnology company, one of the most speculative and volatile marketplace.
2000-2005
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
- Genedata
- Novartis Venture Fund: Valuation dilemmas
- Venture Valuation AG: The genedata assignment
- Genedata
- Novartis Venture Fund: Valuation dilemmas
- Venture Valuation AG: The genedata assignment
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-1-0242 ©2005
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-1-0241 ©2005
Research Information & Knowledge Hub for additional information on IMD publications
Today's business environment is marked by heightened uncertainty, driven by shifting political landscapes, accelerated technological advances, and shifting consumer expectations.
The idea of an EU bond, a common safe asset, has been gaining attention lately, particularly following calls for its introduction this month by former Italian prime minister Mario Draghi.
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD 29 November 2024
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-7-2514 ©2024
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-7-2515 ©2024
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD 19 November 2024
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD 8 November 2024
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications